Swarnim Eye Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.86 M
as on 15-11-2024
- Satisfied Charges ₹ 1.50 Cr
as on 15-11-2024
- Revenue 30.11%
(FY 2023)
- Profit 215.72%
(FY 2023)
- Ebitda 107.59%
(FY 2023)
- Net Worth 86.20%
(FY 2023)
- Total Assets 37.59%
(FY 2023)
About Swarnim Eye Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.86 M. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Daxa Rana and Jagdish Rana serve as directors at the Company.
- CIN/LLPIN
U85110GJ2010PTC062905
- Company No.
062905
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swarnim Eye Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daxa Rana  | Director | 30-Nov-2018 | Current |
| Jagdish Rana | Director | 13-Nov-2010 | Current |
Financial Performance of Swarnim Eye Care.
Swarnim Eye Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.11% increase. The company also saw a substantial improvement in profitability, with a 215.72% increase in profit. The company's net worth Soared by an impressive increase of 86.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swarnim Eye Care?
In 2023, Swarnim Eye Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Freedom (Glasses) Eye Laser Centre Private LimitedActive 25 years 2 monthsJagdish Rana is a mutual person
- Swarnim Eye Care Hospital Baroda Private LimitedActive 12 years 9 months
Jagdish Rana is a mutual person
- Swarnim Eye Care Hospital Rajkot Private LimitedActive 12 years 2 months
Jagdish Rana is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 12 Feb 2020 | ₹9.86 M | Open |
The Kalupur Commercialco Op Bank Ltd Creation Date: 27 May 2011 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Swarnim Eye Care?
Unlock and access historical data on people associated with Swarnim Eye Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swarnim Eye Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swarnim Eye Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
